mate this isn’t a downstream glutamate receptor antagonist. It’s a TRPC channel inhibitor specific for channels 3,6, and 7. It’s a new drug class. Zecs go away mate you’re a troll. It’s the first of its kind and has nothing to do with glutamate
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.015(6.00%) |
Mkt cap ! $50.62M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $76.48K | 319.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43488 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 188333 | 2 |
View Market Depth
| Last trade - 12.25pm 27/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |